Navigation Links
Contract Research Organization WCCT Global Announces Clinical Trial Patient Recruitment Services for International Clinical Studies
Date:11/26/2013

Costa Mesa, Ca (PRWEB) November 26, 2013

Southern California headquartered CRO, WCCT Global, announces today that they have implemented an international patient recruitment strategy. This international patient program is led by the use of an in-depth social media strategy and optimized search engine approach. In addition, WCCT Global has a complete design team that is able to produce any print materials needed for a campaign in any language. Each print material for a study is connected to a digital website where the viewer can scan with their smart phone and sign up for a study without ever having to make a phone call.

This process is extremely cutting-edge and allows for a much higher conversion compared to traditional print materials. The reason WCCT Global decided to add this service offering is because many sponsors initiate clinical sites in the U.S. and in international countries at the same time. This allows the sponsor to not only have one CRO conduct all of the outsourced services for the study, but also centralize all international and domestic recruitment efforts within one organization, ultimately leading to a much more efficient trial. WCCT Global strives to be the best full-service CRO in the industry and adding this service offering allows them to be a CRO that can handle every aspect of a clinical trial.

WCCT Global’s VP of Business Development stated, “WCCT Global is an organization where our sponsors can come to us expecting a complete clinical study plan for every aspect of their study; from recruitment to complete data management, to final study report.”

More about Full-Service CRO WCCT Global:

WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

If you are interested in requesting more information about WCCT Global's capabilities, CLICK HERE.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11368465.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. LogicNets® Announces Contract Award from PALGA Dutch National Pathology Network
2. Texas-Based Agency, Weiser Insurance, Warns Houston Residents of the Increased Danger of Contracting Dengue Fever This Fall
3. Managed Care Advisors Wins BPA Contract Award From Department of Homeland Security for Workers' Compensation Medical Case Management Services
4. FDAnews Management Report: Managing Contract Manufacturers and Testing Labs
5. Restoration Local Seeking Water Damage Repair Contractors To Join Their Network Of Service Provider
6. Pharma Contract Manufacturing: World Market Outlook 2013-2023
7. Morris Government Solutions Wins U.S. Government General Services Administration (GSA) Contract
8. Contract Research Organization WCCT Global Welcomes Edward Kim as Executive Director, Early Clinical Development
9. HUMAN Healthy Vending Wins Several School District Accounts, Lands 60+ School Machine Contracts in Past 120 Days
10. Mississippi Radiation Oncology Practice Signs Contract With Billing Company
11. Orthopedic Market: Contract Manufacturing, Trauma Devices, Bracing & Supports 2016 Forecasts in New Research Reports at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... The Valentine’s Season is famous for gift giving with flowers, chocolates and other ... loved. This year, for more than 5.6 million Americans suffering with Alzheimer’s, those store ... to remind them of the lives they’ve led and the people they’ve touched. ...
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates Insurance & ... community enrichment program, has teamed up with Citizens Opposed to Domestic Abuse in support ... abuse. To support all those victimized by the fear of violence in their own ...
(Date:2/8/2016)... ... February 08, 2016 , ... Remember the old saying “rub some dirt on ... A~, author of “Calcium Bentonite Clay” the health benefits of integrating clay into a ... the body. , A former motivational speaker, Perry A~ has since dedicated her life ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... to share this important news! AHCC and the Home Health and Hospice ICD-10 ... CMS' designee for official ICD coding guidance and clarifications, to address concerns over ...
(Date:2/8/2016)... ... ... According to research by the National Association of Dental ... certified or obtain continuing education. To increase patient awareness of the lack of ... to inform dentists and patients about the possible lack of skills and knowledge ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)...  Labvantage Lx, a newcomer to the dietary ... enhancement product, EnduramenT. Setting a new standard in ... patented biomedical breakthrough molecule that promotes the controlled ... for many biological functions including erectile function. ... the use of prescription medications, scientists working on ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. ... Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that they have ... and commercialization rights for OPA-15406 in the U.S. and ... provides manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase ... dermatitis. --> --> ...
(Date:2/8/2016)... , Feb. 8, 2016  Ventana Medical ... that hundreds of the world,s top oncologists, pathologists, ... at the 12 th annual Tucson Symposium ... evolving theories and new outcomes in cancer research ... patients, lives. Thomas Grogan , annually ...
Breaking Medicine Technology: